The occlusion devices market size has grown strongly in recent years. It will grow from $4.2 billion in 2025 to $4.6 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increase in cardiovascular diseases, advancements in interventional radiology, aging population growth, hospital infrastructure expansion, clinical adoption of embolization.
The occlusion devices market size is expected to see strong growth in the next few years. It will grow to $6.54 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growth in neurological disorders, rising minimally invasive surgeries, technological device innovation, expanding ambulatory care centers, favorable reimbursement policies. Major trends in the forecast period include shift toward minimally invasive procedures, rising use of catheter-based therapies, increasing preference for embolization procedures, growth in neurovascular interventions, demand for high-precision occlusion devices.
The growing demand for minimally invasive techniques is increasingly supporting the expansion of the occlusion devices market going forward. Minimally invasive surgical techniques utilize small incisions or natural body openings to access internal organs and tissues while minimizing physical trauma. These approaches offer clinical, financial, and aesthetic benefits, including reduced recovery time and fewer complications, making them increasingly attractive to patients and healthcare providers. Occlusion devices are used in minimally invasive procedures to block or close blood vessels, ducts, or abnormal pathways and are commonly applied in interventional cardiology, radiology, and related specialties. For example, in June 2024, the International Society of Aesthetic Plastic Surgery reported that total aesthetic procedures approached 35 million in 2023, with combined surgical and non-surgical procedures increasing by 3.4% to reach 34.9 million. As a result, rising demand for minimally invasive techniques is reinforcing growth in the occlusion devices market.
Leading companies in the occlusion devices market are prioritizing the development of innovative solutions, including next-generation devices, to enhance targeted embolization procedures. A next-generation device represents an advanced iteration of existing technology that delivers improved performance, enhanced features, and innovative functionality. For example, in July 2025, Embolx, a US-based medical equipment manufacturer, introduced the Sniper G3 Balloon Occlusion Microcatheter to improve targeted embolization with greater efficiency, ease of use, and extended shelf life. This third-generation device doubles shelf life to 24 months, improving inventory flexibility. Developed using direct feedback from interventional radiologists, it offers enhanced trackability and a simplified preparation process that reduces setup time to under one minute, streamlining workflows and improving procedural outcomes.
In November 2023, Amring Pharmaceuticals Inc., a US-based specialty pharmaceutical company, acquired Laminar Inc. for an undisclosed amount. This acquisition combines Nordic Pharma’s pharmaceutical expertise with Visant’s FDA-cleared hyaluronic acid derivative, LACRIFILL, a canalicular occlusive device designed to temporarily block tear drainage by occluding the canalicular system. Visant Medical Inc. is a US-based medical device manufacturer focused on treatments for dry eye disease.
Major companies operating in the occlusion devices market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., Angiodynamics Inc., LeMaitre Vascular Inc., Elixir Medical Corporation, Vascular Concepts Ltd., Occlutech, W L Gore & Associates Inc., LifeTech Scientific Corporation, Cardiovascular Systems Inc., Venus Medtech, CeloNova Biosciences, Cordis Corporation, Pfizer Inc., Sirtex Medical Limited, Nordion Canada Inc., AtriCure Inc., Phenox GmbH, Balt Extrusion SAS.
North America was the largest region in the occlusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the occlusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the occlusion devices market by raising costs of imported medical-grade metals, polymers, and catheter components. Embolization and occlusion removal devices are most impacted, particularly in North America and Europe where reliance on global suppliers is high. Increased prices have affected procurement budgets for hospitals and surgical centers. On the positive side, tariffs are accelerating local manufacturing initiatives and partnerships, improving supply security and regional production capabilities.
The occlusion devices market research report is one of a series of new reports that provides occlusion devices market statistics, including occlusion devices industry global market size, regional shares, competitors with a occlusion devices market share, detailed occlusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the occlusion devices industry. This occlusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Occlusion devices are medical tools designed to block or restrict the flow of blood or other fluids, commonly used in procedures like embolization to treat aneurysms, vascular abnormalities, or bleeding.
The main product categories of occlusion devices include occlusion removal devices, embolization devices, tubal occlusion devices, and support devices. Occlusion removal devices are medical instruments developed to eliminate blockages in blood vessels or other bodily passages. These devices are used in applications such as neurology, cardiology, peripheral vascular disease treatment, urology, oncology, and gynecology, and the end users include hospitals, diagnostic and surgical centers, ambulatory care centers, research laboratories, and academic institutions.
The occlusion devices market consists of sales of liquid embolic agents, flow diverters, balloon occlusion devices, emblemization coils, and endovascular stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The occlusion devices market size is expected to see strong growth in the next few years. It will grow to $6.54 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growth in neurological disorders, rising minimally invasive surgeries, technological device innovation, expanding ambulatory care centers, favorable reimbursement policies. Major trends in the forecast period include shift toward minimally invasive procedures, rising use of catheter-based therapies, increasing preference for embolization procedures, growth in neurovascular interventions, demand for high-precision occlusion devices.
The growing demand for minimally invasive techniques is increasingly supporting the expansion of the occlusion devices market going forward. Minimally invasive surgical techniques utilize small incisions or natural body openings to access internal organs and tissues while minimizing physical trauma. These approaches offer clinical, financial, and aesthetic benefits, including reduced recovery time and fewer complications, making them increasingly attractive to patients and healthcare providers. Occlusion devices are used in minimally invasive procedures to block or close blood vessels, ducts, or abnormal pathways and are commonly applied in interventional cardiology, radiology, and related specialties. For example, in June 2024, the International Society of Aesthetic Plastic Surgery reported that total aesthetic procedures approached 35 million in 2023, with combined surgical and non-surgical procedures increasing by 3.4% to reach 34.9 million. As a result, rising demand for minimally invasive techniques is reinforcing growth in the occlusion devices market.
Leading companies in the occlusion devices market are prioritizing the development of innovative solutions, including next-generation devices, to enhance targeted embolization procedures. A next-generation device represents an advanced iteration of existing technology that delivers improved performance, enhanced features, and innovative functionality. For example, in July 2025, Embolx, a US-based medical equipment manufacturer, introduced the Sniper G3 Balloon Occlusion Microcatheter to improve targeted embolization with greater efficiency, ease of use, and extended shelf life. This third-generation device doubles shelf life to 24 months, improving inventory flexibility. Developed using direct feedback from interventional radiologists, it offers enhanced trackability and a simplified preparation process that reduces setup time to under one minute, streamlining workflows and improving procedural outcomes.
In November 2023, Amring Pharmaceuticals Inc., a US-based specialty pharmaceutical company, acquired Laminar Inc. for an undisclosed amount. This acquisition combines Nordic Pharma’s pharmaceutical expertise with Visant’s FDA-cleared hyaluronic acid derivative, LACRIFILL, a canalicular occlusive device designed to temporarily block tear drainage by occluding the canalicular system. Visant Medical Inc. is a US-based medical device manufacturer focused on treatments for dry eye disease.
Major companies operating in the occlusion devices market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., Angiodynamics Inc., LeMaitre Vascular Inc., Elixir Medical Corporation, Vascular Concepts Ltd., Occlutech, W L Gore & Associates Inc., LifeTech Scientific Corporation, Cardiovascular Systems Inc., Venus Medtech, CeloNova Biosciences, Cordis Corporation, Pfizer Inc., Sirtex Medical Limited, Nordion Canada Inc., AtriCure Inc., Phenox GmbH, Balt Extrusion SAS.
North America was the largest region in the occlusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the occlusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the occlusion devices market by raising costs of imported medical-grade metals, polymers, and catheter components. Embolization and occlusion removal devices are most impacted, particularly in North America and Europe where reliance on global suppliers is high. Increased prices have affected procurement budgets for hospitals and surgical centers. On the positive side, tariffs are accelerating local manufacturing initiatives and partnerships, improving supply security and regional production capabilities.
The occlusion devices market research report is one of a series of new reports that provides occlusion devices market statistics, including occlusion devices industry global market size, regional shares, competitors with a occlusion devices market share, detailed occlusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the occlusion devices industry. This occlusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Occlusion devices are medical tools designed to block or restrict the flow of blood or other fluids, commonly used in procedures like embolization to treat aneurysms, vascular abnormalities, or bleeding.
The main product categories of occlusion devices include occlusion removal devices, embolization devices, tubal occlusion devices, and support devices. Occlusion removal devices are medical instruments developed to eliminate blockages in blood vessels or other bodily passages. These devices are used in applications such as neurology, cardiology, peripheral vascular disease treatment, urology, oncology, and gynecology, and the end users include hospitals, diagnostic and surgical centers, ambulatory care centers, research laboratories, and academic institutions.
The occlusion devices market consists of sales of liquid embolic agents, flow diverters, balloon occlusion devices, emblemization coils, and endovascular stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Occlusion Devices Market Characteristics
3. Occlusion Devices Market Supply Chain Analysis
4. Global Occlusion Devices Market Trends and Strategies
5. Occlusion Devices Market Analysis of End Use Industries
7. Global Occlusion Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Occlusion Devices Total Addressable Market (TAM) Analysis for the Market
9. Occlusion Devices Market Segmentation
10. Occlusion Devices Market Regional and Country Analysis
11. Asia-Pacific Occlusion Devices Market
12. China Occlusion Devices Market
13. India Occlusion Devices Market
14. Japan Occlusion Devices Market
15. Australia Occlusion Devices Market
16. Indonesia Occlusion Devices Market
17. South Korea Occlusion Devices Market
18. Taiwan Occlusion Devices Market
19. South East Asia Occlusion Devices Market
20. Western Europe Occlusion Devices Market
21. UK Occlusion Devices Market
22. Germany Occlusion Devices Market
23. France Occlusion Devices Market
24. Italy Occlusion Devices Market
25. Spain Occlusion Devices Market
26. Eastern Europe Occlusion Devices Market
27. Russia Occlusion Devices Market
28. North America Occlusion Devices Market
29. USA Occlusion Devices Market
30. Canada Occlusion Devices Market
31. South America Occlusion Devices Market
32. Brazil Occlusion Devices Market
33. Middle East Occlusion Devices Market
34. Africa Occlusion Devices Market
36. Occlusion Devices Market Competitive Landscape and Company Profiles
37. Occlusion Devices Market Other Major and Innovative Companies
40. Occlusion Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Occlusion Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses occlusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for occlusion devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The occlusion devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Occlusion Removal Devices; Embolization Devices; Tubal Occlusion Devices; Support Devices2) By Application: Neurology; Cardiology; Peripheral Vascular Diseases; Urology; Oncology; Gynecology
3) By End User: Hospitals Diagnostic Centers And Surgical Centers; Ambulatory Care Centers; Research Laboratories And Academic Institutes
Subsegments:
1) By Occlusion Removal Devices: Thrombectomy Devices; Catheter-Based Occlusion Removal Devices; Aspiration Systems; Mechanical Clot Retrieval Systems2) By Embolization Devices: Coil Embolization Devices; Particle Embolization Devices; Balloon Embolization Devices; Gel Embolic Agents; Liquid Embolic Agents; Stent-Assisted Embolization Devices
3) By Tubal Occlusion Devices: Essure Devices; Hysteroscopic Sterilization Systems; Fallopian Tube Clips; Tubal Ligation Devices
4) By Support Devices: Occlusion Catheters; Guidewires For Occlusion; Supportive Sheaths; Stent-Grafts For Occlusion Support
Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B. Braun Melsungen AG; Terumo Corporation; Cook Group Incorporated; Merit Medical Systems Inc.; Lepu Medical Technology Beijing Co. Ltd.; MicroPort Scientific Corporation; Penumbra Inc.; Asahi Intecc Co. Ltd.; Angiodynamics Inc.; LeMaitre Vascular Inc.; Elixir Medical Corporation; Vascular Concepts Ltd.; Occlutech; W L Gore & Associates Inc.; LifeTech Scientific Corporation; Cardiovascular Systems Inc.; Venus Medtech; CeloNova Biosciences; Cordis Corporation; Pfizer Inc.; Sirtex Medical Limited; Nordion Canada Inc.; AtriCure Inc.; Phenox GmbH; Balt Extrusion SAS
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Occlusion Devices market report include:- Johnson & Johnson
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Terumo Corporation
- Cook Group Incorporated
- Merit Medical Systems Inc.
- Lepu Medical Technology Beijing Co. Ltd.
- MicroPort Scientific Corporation
- Penumbra Inc.
- Asahi Intecc Co. Ltd.
- Angiodynamics Inc.
- LeMaitre Vascular Inc.
- Elixir Medical Corporation
- Vascular Concepts Ltd.
- Occlutech
- W L Gore & Associates Inc.
- LifeTech Scientific Corporation
- Cardiovascular Systems Inc.
- Venus Medtech
- CeloNova Biosciences
- Cordis Corporation
- Pfizer Inc.
- Sirtex Medical Limited
- Nordion Canada Inc.
- AtriCure Inc.
- Phenox GmbH
- Balt Extrusion SAS
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.6 Billion |
| Forecasted Market Value ( USD | $ 6.54 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
